Remote Patient Monitoring Program for Hospital Discharged COVID-19 Patients.


Journal

Applied clinical informatics
ISSN: 1869-0327
Titre abrégé: Appl Clin Inform
Pays: Germany
ID NLM: 101537732

Informations de publication

Date de publication:
10 2020
Historique:
entrez: 26 11 2020
pubmed: 27 11 2020
medline: 15 12 2020
Statut: ppublish

Résumé

We deployed a Remote Patient Monitoring (RPM) program to monitor patients with coronavirus disease 2019 (COVID-19) upon hospital discharge. We describe the patient characteristics, program characteristics, and clinical outcomes of patients in our RPM program. We enrolled COVID-19 patients being discharged home from the hospital. Enrolled patients had an app, and were provided with a pulse oximeter and thermometer. Patients self-reported symptoms, O A total of 295 patients were referred for RPM from five participating hospitals, and 225 patients were enrolled. A majority of enrolled patients (66%) completed the monitoring period without triggering an abnormal alert. Enrollment was associated with a decreased odds of ED or hospital readmission (adjusted odds ratio: 0.54; 95% confidence interval: 0.3-0.97; RPM for COVID-19 provides a mechanism to monitor patients in their home environment and reduce hospital utilization. Our work suggests that RPM reduces readmissions for patients with COVID-19 and provides scalable remote monitoring capabilities upon hospital discharge. RPM for postdischarge patients with COVID-19 was associated with a decreased risk of readmission to the ED or hospital, and provided a scalable mechanism to monitor patients in their home environment.

Identifiants

pubmed: 33241547
doi: 10.1055/s-0040-1721039
pmc: PMC7688410
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

792-801

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

W.J.G. reports research funding from IBM, outside the scope of this study. W.J.G. reports consulting income from the Office of the National Coordinator, U.S. Department of Health and Human Services, outside the scope of this study. D.M.L. reports grants from Biofourmis, outside the submitted work.

Références

N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
PLoS One. 2016 Nov 15;11(11):e0165908
pubmed: 27846287
Appl Clin Inform. 2020 May;11(3):452-459
pubmed: 32610350
Appl Clin Inform. 2019 Aug;10(4):707-718
pubmed: 31533172
Appl Clin Inform. 2014 Mar 12;5(1):232-48
pubmed: 24734136
Cleve Clin J Med. 2020 Jun 11;:
pubmed: 32409432
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
J Clin Med. 2020 Apr 24;9(4):
pubmed: 32344679
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
Kidney Int Rep. 2017 Jul 29;2(6):1009-1017
pubmed: 29634048
NPJ Digit Med. 2020 May 4;3:64
pubmed: 32377575
Circulation. 2011 May 3;123(17):1873-80
pubmed: 21444883
N Engl J Med. 2020 May 7;382(19):e52
pubmed: 32329973
N Engl J Med. 2010 Dec 9;363(24):2301-9
pubmed: 21080835
Clin Cardiol. 2019 Feb;42(2):285-291
pubmed: 30582181
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
J Telemed Telecare. 2012 Jun;18(4):211-20
pubmed: 22674020
Appl Clin Inform. 2017 Oct;8(4):1106-1116
pubmed: 29241248
J Med Internet Res. 2017 Jan 20;19(1):e18
pubmed: 28108430
JAMA Intern Med. 2016 Mar;176(3):310-8
pubmed: 26857383
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
Med Biol Eng Comput. 2018 Apr;56(4):547-569
pubmed: 29504070
Lancet. 2020 Apr 11;395(10231):1180-1181
pubmed: 32278374
Telemed J E Health. 2017 Jan;23(1):3-17
pubmed: 27116181
NPJ Digit Med. 2018 Jan 15;1:20172
pubmed: 31304346
N Engl J Med. 2016 Jul 14;375(2):154-61
pubmed: 27410924
Clin Infect Dis. 2020 Jun 20;:
pubmed: 32562416
Eur J Heart Fail. 2011 Sep;13(9):1028-40
pubmed: 21733889
Appl Clin Inform. 2014 Jul 02;5(3):612-20
pubmed: 25298802
J Infect. 2020 May;80(5):e1-e6
pubmed: 32171869
Appl Clin Inform. 2020 Mar;11(2):265-275
pubmed: 32268390
JAMA. 2020 Jun 2;323(21):2127-2128
pubmed: 32364565
J Travel Med. 2020 Nov 9;27(7):
pubmed: 32706375
BMC Health Serv Res. 2018 Jun 26;18(1):495
pubmed: 29940936
JAMA. 2020 Jun 16;323(23):2375-2376
pubmed: 32421170
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
JAMA. 2020 May 12;323(18):1773-1774
pubmed: 32219367
J Am Med Inform Assoc. 2020 Aug 1;27(8):1326-1330
pubmed: 32392280
J Korean Med Sci. 2020 Apr 06;35(13):e140
pubmed: 32242347
J Am Med Inform Assoc. 2020 Nov 1;27(11):1825-1827
pubmed: 32667985
BMJ. 2020 May 22;369:m1985
pubmed: 32444460

Auteurs

William J Gordon (WJ)

Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States.
Harvard Medical School, Boston, Massachusetts, United States.

Daniel Henderson (D)

Harvard Medical School, Boston, Massachusetts, United States.
Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States.

Avital DeSharone (A)

Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States.

Herrick N Fisher (HN)

Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.
Harvard Medical School, Boston, Massachusetts, United States.

Jessica Judge (J)

Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.

David M Levine (DM)

Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.
Harvard Medical School, Boston, Massachusetts, United States.

Laura MacLean (L)

Brigham and Women's Hospital, Boston, Massachusetts, United States.

Diane Sousa (D)

Brigham and Women's Hospital, Boston, Massachusetts, United States.

Mack Y Su (MY)

Harvard Medical School, Boston, Massachusetts, United States.

Robert Boxer (R)

Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.
Harvard Medical School, Boston, Massachusetts, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH